D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 133 SEK -3.62% Market Closed
Market Cap: 2.2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Total Current Liabilities Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Total Current Liabilities
kr62.9m
CAGR 3-Years
31%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Current Liabilities
kr195.7m
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Current Liabilities
kr107.9m
CAGR 3-Years
28%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Current Liabilities
kr724m
CAGR 3-Years
43%
CAGR 5-Years
27%
CAGR 10-Years
20%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Current Liabilities
kr13.9B
CAGR 3-Years
21%
CAGR 5-Years
27%
CAGR 10-Years
34%
BioArctic AB
STO:BIOA B
Total Current Liabilities
kr125m
CAGR 3-Years
5%
CAGR 5-Years
-18%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Total Current Liabilities?
Total Current Liabilities
62.9m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Total Current Liabilities amounts to 62.9m SEK.

What is Devyser Diagnostics AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
45%

Over the last year, the Total Current Liabilities growth was 23%. The average annual Total Current Liabilities growth rates for Devyser Diagnostics AB have been 31% over the past three years , 45% over the past five years .

Back to Top